​

Anuh Pharma Limited

BSE:506260 Stock Report

Market Cap: ₹10.7b

Anuh Pharma (506260) Stock Overview

Engages in the manufacture and sale of bulk drugs and chemicals in India. More details

506260 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Rewards

Price-To-Earnings ratio (22.7x) is below the Indian market (29.5x)

Risk Analysis

Unstable dividend track record


506260 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Anuh Pharma Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Anuh Pharma
Historical stock prices
Current Share Price₹214.40
52 Week High₹249.95
52 Week Low₹148.05
Beta0.45
1 Month Change0.37%
3 Month Change28.58%
1 Year Change-6.72%
3 Year Change140.76%
5 Year Change99.21%
Change since IPO1,123.99%

Recent News & Updates

Recent updates

Shareholder Returns

506260IN PharmaceuticalsIN Market
7D0.8%0.4%0.06%
1Y-6.7%8.3%-1.2%

Return vs Industry: 506260 underperformed the Indian Pharmaceuticals industry which returned 8.5% over the past year.

Return vs Market: 506260 underperformed the Indian Market which returned -1.5% over the past year.

Price Volatility

Is 506260's price volatile compared to industry and market?
506260 volatility
506260 Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement5.8%
10% most volatile stocks in IN Market8.5%
10% least volatile stocks in IN Market3.9%

Stable Share Price: 506260 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 506260's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1960175Ritesh Shahwww.anuhpharma.com

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and intermediates. The company also provides corticosteroids, such as anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, and anti-histamines.

Anuh Pharma Limited Fundamentals Summary

How do Anuh Pharma's earnings and revenue compare to its market cap?
506260 fundamental statistics
Market cap₹10.74b
Earnings (TTM)₹473.52m
Revenue (TTM)₹6.62b
22.7x
P/E Ratio
1.6x
P/S Ratio

Is 506260 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
506260 income statement (TTM)
Revenue₹6.62b
Cost of Revenue₹4.99b
Gross Profit₹1.62b
Other Expenses₹1.15b
Earnings₹473.52m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)9.45
Gross Margin24.51%
Net Profit Margin7.16%
Debt/Equity Ratio3.2%

How did 506260 perform over the long term?

See historical performance and comparison

Dividends

0.7%
Current Dividend Yield
16%
Payout Ratio

Does 506260 pay a reliable dividends?

See 506260 dividend history and benchmarks
When do you need to buy 506260 by to receive an upcoming dividend?
Anuh Pharma dividend dates
Ex Dividend DateAug 14 2025
Dividend Pay DateSep 21 2025
Days until Ex dividend35 days
Days until Dividend pay date73 days

Does 506260 pay a reliable dividends?

See 506260 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/09 11:07
End of Day Share Price 2025/07/09 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Anuh Pharma Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research